These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 9878310

  • 21. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
    Pan SS, Akman SA, Forrest GL, Hipsher C, Johnson R.
    Cancer Chemother Pharmacol; 1992; 31(1):23-31. PubMed ID: 1458556
    [Abstract] [Full Text] [Related]

  • 22. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
    Begleiter A, Leith MK.
    Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
    [Abstract] [Full Text] [Related]

  • 23. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D, Gibson NW, Preusch PC, Ross D.
    Cancer Res; 1990 Dec 01; 50(23):7483-9. PubMed ID: 1701346
    [Abstract] [Full Text] [Related]

  • 24. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
    Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T.
    Gan To Kagaku Ryoho; 1993 Jun 01; 20(8):1037-41. PubMed ID: 7685584
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 26. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
    Yao KS, Godwin AK, Johnson C, O'Dwyer PJ.
    Cancer Res; 1996 Apr 15; 56(8):1731-6. PubMed ID: 8620484
    [Abstract] [Full Text] [Related]

  • 27. Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.
    Sagara N, Katoh M.
    Cancer Res; 2000 Nov 01; 60(21):5959-62. PubMed ID: 11085512
    [Abstract] [Full Text] [Related]

  • 28. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Scalamogna D, Xia H, O'Toole S, Roy D, Emerson EO, Gupta V, Zaren HA.
    Int J Cancer; 1996 Mar 15; 65(6):852-7. PubMed ID: 8631603
    [Abstract] [Full Text] [Related]

  • 29. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK, Long BH, Chakrabarty S, Brattain DE, Brattain MG.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [Abstract] [Full Text] [Related]

  • 30. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
    Begleiter A, Robotham E, Leith MK.
    Mol Pharmacol; 1992 Apr 15; 41(4):677-82. PubMed ID: 1373799
    [Abstract] [Full Text] [Related]

  • 31. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
    Willson JK, Long BH, Marks ME, Brattain DE, Wiley JE, Brattain MG.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5880-5. PubMed ID: 6437674
    [Abstract] [Full Text] [Related]

  • 32. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 33. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
    Yoshida T, Tsuda H.
    Biochem Biophys Res Commun; 1995 Sep 14; 214(2):701-8. PubMed ID: 7677784
    [Abstract] [Full Text] [Related]

  • 34. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 14; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 35. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
    Sakamoto N, Toge T, Nishiyama M.
    Hiroshima J Med Sci; 1997 Jun 14; 46(2):67-73. PubMed ID: 9232934
    [Abstract] [Full Text] [Related]

  • 36. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D, Gibson NW, Preusch PC, Ross D.
    Cancer Res; 1990 Nov 15; 50(22):7293-300. PubMed ID: 2121335
    [Abstract] [Full Text] [Related]

  • 37. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
    Dulhanty AM, Whitmore GF.
    Cancer Res; 1991 Apr 01; 51(7):1860-5. PubMed ID: 1900739
    [Abstract] [Full Text] [Related]

  • 38. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells.
    Baumann RP, Hodnick WF, Seow HA, Belcourt MF, Rockwell S, Sherman DH, Sartorelli AC.
    Cancer Res; 2001 Nov 01; 61(21):7770-6. PubMed ID: 11691791
    [Abstract] [Full Text] [Related]

  • 39. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
    Begleiter A, Leith MK, Curphey TJ, Doherty GP.
    Oncol Res; 1997 Nov 01; 9(6-7):371-82. PubMed ID: 9406243
    [Abstract] [Full Text] [Related]

  • 40. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR, Fracasso PM, Heimbrook DC, Rockwell S, Sligar SG, Sartorelli AC.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.